Add Company
Join Now

ApolloMD Incorporated Revenue and Competitors

License our Company Data API

Atlanta, GA USA

Location

$12M

Total Funding

Medical Offices

Industry

Estimated Revenue & Valuation

  • ApolloMD Incorporated's estimated annual revenue is currently $434.7M per year.(i)
  • ApolloMD Incorporated's estimated revenue per employee is $378,000
  • ApolloMD Incorporated's total funding is $12M.

Employee Data

  • ApolloMD Incorporated has 1150 Employees.(i)
  • ApolloMD Incorporated grew their employee count by 6% last year.

ApolloMD Incorporated's People

NameTitleEmail/Phone
1
Chief Medical OfficerReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Talent OfficerReveal Email/Phone
4
CIO/CTOReveal Email/Phone
5
Chief MemberReveal Email/Phone
6
Chief Growth OfficerReveal Email/Phone
7
General Counsel and Chief Compliance OfficerReveal Email/Phone
8
Sr. VP OperationsReveal Email/Phone
9
Chief Medical Officer and President, Hospital MedicineReveal Email/Phone
10
Chief Talent OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M390%N/AN/A
#2
$28.4M10544%N/AN/A
#3
$117.5M348-3%N/AN/A
#4
$22.4M8326%N/AN/A
#5
$15.8M650%N/AN/A
#6
$55.2M186-3%N/AN/A
#7
$60M202N/AN/AN/A
#8
$30.5M113-27%N/AN/A
#9
$41.6M1400%N/AN/A
#10
$46.3M15616%N/AN/A
Add Company

What Is ApolloMD Incorporated?

ApolloMD is a physician-owned, physician-run group practice. The physicians and hospitals we serve are our key stakeholders, and we avoid marketplace downfalls by maintaining that focus. At ApolloMD, we have the feel of a local group, with the resources of a national group. Our purpose and goal is to make every hospital in which we operate the best it can possibly be - both for the patients and the hospital itself.

keywords:N/A

$12M

Total Funding

1150

Number of Employees

$434.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$303.8M124013%N/A
#2
$259M1276N/AN/A
#3
$279.7M12878%N/A
#4
$580.5M1331-13%N/A
#5
$1110M14114%N/A